Abstract:BackgroundThe production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular 'reactive oxygen species' (ROSs) can exhibit a number of biological effects, they are not of themselves excessively reactive and thus they are not especially damaging at physiological concentrations. However, their reactions with poorly liganded iron species can lead to the catalytic production of the very reactive and dangerous hydroxyl radical, which is exceptionally damaging, and a major cause of chronic inflammation.ReviewWe review the considerable and wide-ranging evidence for the involvement of this combination of (su)peroxide and poorly liganded iron in a large number of physiological and indeed pathological processes and inflammatory disorders, especially those involving the progressive degradation of cellular and organismal performance. These diseases share a great many similarities and thus might be considered to have a common cause (i.e. iron-catalysed free radical and especially hydroxyl radical generation).The studies reviewed include those focused on a series of cardiovascular, metabolic and neurological diseases, where iron can be found at the sites of plaques and lesions, as well as studies showing the significance of iron to aging and longevity. The effective chelation of iron by natural or synthetic ligands is thus of major physiological (and potentially therapeutic) importance. As systems properties, we need to recognise that physiological observables have multiple molecular causes, and studying them in isolation leads to inconsistent patterns of apparent causality when it is the simultaneous combination of multiple factors that is responsible.This explains, for instance, the decidedly mixed effects of antioxidants that have been observed, since in some circumstances (especially the presence of poorly liganded iron) molecules that are nominally antioxidants can actually act as pro-oxidants. The reduction of redox stress thus requires suitable levels of both antioxidants and effective iron chelators. Some polyphenolic antioxidants may serve both roles.Understanding the exact speciation and liganding of iron in all its states is thus crucial to separating its various pro- and anti-inflammatory activities. Redox stress, innate immunity and pro- (and some anti-)inflammatory cytokines are linked in particular via signalling pathways involving NF-kappaB and p38, with the oxidative roles of iron here seemingly involved upstream of the IkappaB kinase (IKK) reaction. In a number of cases it is possible to identify mechanisms by which ROSs and poorly liganded iron act synergistically and autocatalytically, leading to 'runaway' reactions that are hard to control unless one tackles multiple sites of action simultaneously. Some molecules such as statins and erythropoietin, not traditionally associated with anti-inflammatory activity, do indeed have 'pleiotropic' anti-inflammatory effects that may be of benefit here.ConclusionOverall we argue, by synthesising a widely dispersed literature, that the role of poorly liganded iron has been rather underappreciated in the past, and that in combination with peroxide and superoxide its activity underpins the behaviour of a great many physiological processes that degrade over time. Understanding these requires an integrative, systems-level approach that may lead to novel therapeutic targets.

Iron and Atherosclerosis: The Link Revisited.

Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction

The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice

The role of iron in the pathogenesis of atherosclerosis

Iron metabolism and atherosclerosis development

The Role of Iron in Atherosclerosis and its Association with Related Diseases

Ironing out Macrophages in Atherosclerosis

Iron Enhances the Neurotoxicity of Amyloid β

Analysis of mechanism, therapeutic strategies, and potential natural compounds against atherosclerosis by targeting iron overload-induced oxidative stress

Iron accumulation in macrophages promotes the formation of foam cells and development of atherosclerosis

Iron Status and NAFLD among European Populations: A Bidirectional Two-Sample Mendelian Randomization Study

The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis

Appraising the Causal Association Between Systemic Iron Status and Heart Failure Risk: A Mendelian Randomisation Study

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications

Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases

Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?

The expression and mechanism of iron/cholesterol metabolism protein in atherosclerosis progression

Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages

Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles

Macrophage Iron Accumulation Promotes the Development of Atherosclerosis in Apolipoprotein E Knockout Mice

Abstract TMP114: The Role of Iron Mediated Oxidative Stress and Lipid Peroxidation in the Development of Intracranial Aneurysm Rupture